Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Holding GB:AGY?
Track your performance easily
AGY Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range1.80p - 6.50p
Previous Close6.4p
Volume266.66K
Average Volume (3M)432.18K
Market Cap
£305.05M
Enterprise Value326.20M
Total Cash (Recent Filing)£14.85M
Total Debt (Recent Filing)£35.99M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Mar 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding4,766,439,938
10 Day Avg. Volume604,011
30 Day Avg. Volume432,184
Standard Deviation0.34
R-Squared0.04
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)5.12
Price to Cash Flow (P/CF)-7.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Allergy Therapeutics News
PremiumCompany Announcements
Allergy Therapeutics Rectifies Share Option Oversight
PremiumCompany Announcements
Allergy Therapeutics Shows Promising Results for Peanut Allergy
PremiumCompany Announcements
Allergy Therapeutics Begins Innovative Paediatric Allergy Trial
PremiumCompany Announcements
Allergy Therapeutics Seeks Approval for Grass Allergy TreatmentPremiumCompany Announcements
Allergy Therapeutics Unveils Incentive Plans and Share RepurchasePremiumCompany Announcements
Allergy Therapeutics Sees Growth and Strategic Advances
PremiumCompany Announcements
Allergy Therapeutics Shows Financial Turnaround and Clinical Progress
PremiumCompany Announcements
Allergy Therapeutics Launches Pediatric Trial for Allergy VaccineOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors
AGY FAQ
What was Allergy Therapeutics PLC’s price range in the past 12 months?
Allergy Therapeutics PLC lowest share price was 1.80p and its highest was 6.50p in the past 12 months.
What is Allergy Therapeutics PLC’s market cap?
Currently, no data Available
When is Allergy Therapeutics PLC’s upcoming earnings report date?
Allergy Therapeutics PLC’s upcoming earnings report date is Mar 05, 2025 which is in 72 days.
How were Allergy Therapeutics PLC’s earnings last quarter?
Allergy Therapeutics PLC released its earnings results on Nov 06, 2024. The company reported -0.005p earnings per share for the quarter, the consensus estimate of -0.005p by 0p.
Is Allergy Therapeutics PLC overvalued?
According to Wall Street analysts Allergy Therapeutics PLC’s price is currently Overvalued.
Does Allergy Therapeutics PLC pay dividends?
Allergy Therapeutics PLC does not currently pay dividends.
What is Allergy Therapeutics PLC’s EPS estimate?
Allergy Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allergy Therapeutics PLC have?
Allergy Therapeutics PLC has 4,766,440,000 shares outstanding.
What happened to Allergy Therapeutics PLC’s price movement after its last earnings report?
Allergy Therapeutics PLC reported an EPS of -0.005p in its last earnings report, expectations of -0.005p. Following the earnings report the stock price went up 1.476%.
Which hedge fund is a major shareholder of Allergy Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:AGY
---
Allergy Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
190.90%
12-Months-Change
Fundamentals
Return on Equity
-1392.76%
Trailing 12-Months
Asset Growth
-2.91%
Trailing 12-Months
Company Description
Allergy Therapeutics PLC
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
---
Technical Analysis
Advanced Medical Solutions
―
Creo Medical
―
EKF Diagnostics Holdings
―
Benchmark Holdings
―
---